Protein intake and muscle mass maintenance in patients with cancer types with high prevalence of sarcopenia: a systematic review

Capitão, Carolina; Coutinho, D.; Neves, Pedro; Capelas, Manuel Luís; Pimenta, Nuno; Santos, Teresa; Mäkitie, Antti; Ravasco, Paula

doi:10.1016/j.clnesp.2021.09.493

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a systematic review involving clinical trials, Capitao et al have observed that protein intake above 1.4g/kg/day is required to maintain muscle mass in cancer patients with sarcopenia undergoing treatment. Protein intake below 1.2g/kg/day was associated with loss of muscle mass in these patients [34]. Furthermore, Deer et al report that the currently recommended protein intake for older adults (0.8g/kg/day) is inadequate to maintain muscle mass and apart from the quantity, the distribution of protein consumption throughout the day may also have an effect [35].…”

Section: Editors Emeritusmentioning

confidence: 93%

See 1 more Smart Citation

Sarcopenia: clinical consequences and management

Lekamwasam

2022

Ceylon Med. J.

View full text Add to dashboard Cite

Section: Editors Emeritusmentioning

confidence: 93%

“…Sarcopenia can be a consequence of an array of diseases or conditions. These include, but not Ceylon Medical Journal 2022; 67: [33][34][35][36] Sarcopenia: clinical consequences and management DOI: http://doi.org/10.4038/cmj.v67i2.9627…”

Section: The Ceylon Medical Journal Established 1887mentioning

confidence: 99%

Sarcopenia: clinical consequences and management

Lekamwasam

2022

Ceylon Med. J.

View full text Add to dashboard Cite

“…As previously mentioned, international guidelines recommend a daily protein intake >1.0 g/kg BW/day and up to 1.5 g/kg BW/day. However, whether a higher limit should be considered for patients receiving active treatments has been recently addressed in a systematic review [16]. The authors identified eight studies, only one of which was a randomized clinical trial.…”

Section: High Protein Diets In Patients Receiving Anticancer Therapiesmentioning

confidence: 99%

High protein diet in digestive cancers

Laviano¹

2022

Current Opinion in Clinical Nutrition &Amp; Metabolic Care

View full text Add to dashboard Cite

Purpose of reviewRecent advances in the nutritional management of patients with digestive cancers suggest that modulation of protein intake may significantly contribute to achieve nutritional and clinical benefits. By reviewing the available evidence, a quantitatively and qualitatively optimal protein intake could be derived.Recent findingsHigh protein diets (i.e., 1–1.5 g/kg body weight/day) appear key to maintain the adequate nutritional status, and may also contribute to achieve clinical benefits. This target appears particularly relevant in patients with digestive cancers at risk or already malnourished, or in older patients. During active cancer treatments, protein intake should be closer to the upper limit of the recommended intake. Also, high protein intake should be maintained beyond the periods of catabolic crisis associated with active treatments. In contrast with general reasoning, animal proteins should represent the majority of the recommended intake. Based on the available evidence, the intake of no specific amino acid can be strongly recommended to enhance anabolic potentials or the immune modulating effects of high protein diets.SummaryHigh protein intake, mostly based on animal proteins, should be recommended to patients with digestive cancers. However, this target should be translated into clinical prescription after considering the clinical and metabolic needs of the patients. The quest for the optimal protein intake of patients with cancer at different time points of their clinical journey is still open.

show abstract

Protein intake and muscle mass maintenance in patients with cancer types with high prevalence of sarcopenia: a systematic review

Cited by 2 publications

References 0 publications

Sarcopenia: clinical consequences and management

Sarcopenia: clinical consequences and management

High protein diet in digestive cancers

Contact Info

Product

Resources

About